Research Designation:Dual-Action Bio-Regenerative Protocol
Technical Overview:
A high-synergy combination of BPC-157 (Body Protective Compound) and TB-500 (Thymosin Beta-4). While BPC-157 targets localized healing of tendons and the gut, TB-500 promotes systemic cellular migration and tissue repair.
Primary Research Objectives:
- Rapid Injury Recovery: The premier research protocol for accelerating the healing of ACL, MCL, and muscle tears.
- Inflammation Modulation: Studied for its ability to significantly down-regulate systemic inflammatory markers and improve joint mobility.
Standard:
Co-packaged for researcher convenience. Known for its “healing-accelerator” profile in high-intensity training environments.
-
Purity: ≥99% (HPLC Verified).
-
Concentration: 10mg Lyophilized Powder.
-
Reconstitution: Includes 3ml Sterile Bacteriostatic (BAC) Water.
-
Storage: Recommended storage at 2°C – 8°C (Refrigerated) after reconstitution.






